Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Asks Genentech To Add Boxed Anaphylaxis Warning To Xolair Label

This article was originally published in The Pink Sheet Daily

Executive Summary

Continued post-marketing reports of anaphylaxis, some well after treatment, led agency to ask for label revision.

You may also be interested in...



Critical Breathes Easier After Finding Promotion Partner For Pending Asthma Therapy

Deal with Merck KGaA subsidiary DEY for zileuton CR adds more than 200 reps and expertise in detailing to respiratory physicians.

Critical Breathes Easier After Finding Promotion Partner For Pending Asthma Therapy

Deal with Merck KGaA subsidiary DEY for zileuton CR adds more than 200 reps and expertise in detailing to respiratory physicians.

Genentech’s Tanox Acquisition Delayed Due to FTC Information Request

Firms expect $919 million deal to close by mid-year.

Topics

UsernamePublicRestriction

Register

PS065662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel